CureVac Historical Cash Flow
| CVAC Stock | USD 3.96 0.18 4.35% |
Analysis of CureVac NV cash flow over time is an excellent tool to project CureVac NV future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 510 M or Depreciation of 15.5 M as it is a great indicator of CureVac NV ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining CureVac NV latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CureVac NV is a good buy for the upcoming year.
CureVac |
About CureVac Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in CureVac balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which CureVac's non-liquid assets can be easily converted into cash.
CureVac NV Cash Flow Chart
Add Fundamental
Depreciation
Depreciation indicates how much of CureVac NV value has been used up. For tax purposes CureVac NV can deduct the cost of the tangible assets it purchases as business expenses. However, CureVac NV must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Capital Expenditures
Capital Expenditures are funds used by CureVac NV to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of CureVac NV operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from CureVac NV's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into CureVac NV current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.At present, CureVac NV's Other Non Cash Items is projected to decrease significantly based on the last few years of reporting. The current year's Capital Expenditures is expected to grow to about 64.3 M, whereas Change To Inventory is forecasted to decline to (44.4 M).
CureVac NV cash flow statement Correlations
Click cells to compare fundamentals
CureVac NV Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CureVac NV cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (8.3M) | (227.5M) | (47.9M) | (47.0M) | (42.3M) | (44.4M) | |
| Investments | (1.2M) | (127.9M) | (93.5M) | (61.7M) | (55.6M) | (58.3M) | |
| Change In Cash | 1.3B | (511.1M) | (315.7M) | (93.3M) | (84.0M) | (79.8M) | |
| Stock Based Compensation | 14.2M | 15.0M | 9.2M | 7.7M | 8.9M | 11.3M | |
| Free Cash Flow | 475.1M | (861.0M) | (379.4M) | (323.1M) | (290.8M) | (305.3M) | |
| Change In Working Capital | 578.6M | (69.5M) | (125.6M) | (68.3M) | (61.5M) | (58.4M) | |
| Begin Period Cash Flow | 30.7M | 1.3B | 811.5M | 495.8M | 570.2M | 510.0M | |
| Other Cashflows From Financing Activities | (45.3M) | (127.9M) | (93.5M) | (55.2M) | (49.7M) | (52.2M) | |
| Depreciation | 10.7M | 15.7M | 23.7M | 23.4M | 26.9M | 15.5M | |
| Other Non Cash Items | 51.6M | (480.7M) | 57.2M | 29.5M | 26.5M | 27.9M | |
| Capital Expenditures | 47.4M | 127.9M | 93.2M | 55.2M | 63.5M | 64.3M | |
| Total Cash From Operating Activities | 522.4M | (733.1M) | (286.2M) | (267.9M) | (241.1M) | (253.2M) | |
| Change To Account Receivables | (32.3M) | (19.8M) | (16.7M) | (7.9M) | (7.1M) | (7.5M) | |
| Net Income | (129.8M) | (412.5M) | (249.2M) | (260.2M) | (234.2M) | (245.9M) | |
| Total Cash From Financing Activities | 819.8M | 345.0M | 63.2M | 230.9M | 265.5M | 279.9M | |
| End Period Cash Flow | 1.3B | 811.5M | 495.8M | 402.5M | 462.8M | 565.5M | |
| Other Cashflows From Investing Activities | 3.2M | (3.7M) | (5.2M) | (2.9M) | (2.6M) | (2.5M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.49 | Revenue Per Share | Quarterly Revenue Growth 0.905 | Return On Assets | Return On Equity |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.